Affimed Announces Proposed Public Offering of Common Stock
Jan 19, 2017 21:02 pm UTC| Business
Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that it has commenced an underwritten public offering of...
Jan 19, 2017 21:01 pm UTC| Business
KILGORE, Texas, Jan. 19, 2017 -- Martin Midstream Partners L.P. (NASDAQ:MMLP) announced today it has declared a quarterly cash distribution of $0.50 per unit, or $2.00 per unit on an annualized basis, for the quarter...
Avinger Announces Presentations Showcasing Lumivascular Technology at Leipzig Interventional Course
Jan 19, 2017 21:01 pm UTC| Business
REDWOOD CITY, Calif., Jan. 19, 2017 -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of abstracts and sessions highlighting the...
American Red Cross Receives $40,000 Donation From PRA Group
Jan 19, 2017 21:00 pm UTC| Business
NORFOLK, Va., Jan. 19, 2017 -- The American Red Cross of Coastal Virginia has received a $40,000 donation from Norfolk, Va.-basedPRA Group, Inc. (Nasdaq:PRAA), a global leader in acquiring and collecting nonperforming...
American River Bankshares Schedules its Quarterly Conference Call
Jan 19, 2017 21:00 pm UTC| Business
SACRAMENTO, Calif., Jan. 19, 2017 -- American River Bankshares (NASDAQ:AMRB) today announced that it will host a conference call on Thursday, January 26, 2017 at 1:30 p.m. Pacific Time to discuss fourth quarter 2016...
Aquesta Financial Holdings, Inc Announces Earnings and Growth for 2016 and the Fourth Quarter
Jan 19, 2017 20:51 pm UTC| Business
CORNELIUS, N.C., Jan. 19, 2017 -- Aquesta Financial Holdings, Inc and subsidiaries – including its primary subsidiary Aquesta Bank (“Aquesta”) (OTC Market symbol AQFH) announced today excellent earnings and loan growth...
Jan 19, 2017 20:30 pm UTC| Business
Durable responses observed in patients with Wnt-pathway genetic mutations CAMBRIDGE, Mass., Jan. 19, 2017 -- Leap Therapeutics, Inc. reported updated clinical and biomarker data from an ongoing study of DKN-01, a...